Caricamento...
The place of tumor necrosis factor alpha inhibitors in the treatment of rheumatoid arthritis patients: tactics in different variants of the disease
As the period of use of genetically engineered biologic drugs (GEBD) in clinical practice is growing, clinicians are faced with new questions: how to switch from one GEBD to another in case of primary or secondary inefficacy, intolerance to previous GEBD therapy; what should be done after low diseas...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
Remedium Group LLC
2015-12-01
|
| Serie: | Медицинский совет |
| Soggetti: | |
| Accesso online: | https://www.med-sovet.pro/jour/article/view/180 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|